Published in Eur Respir J on May 01, 1997
Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med (2008) 4.05
Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J (1997) 0.79
Treatment of snoring with positional therapy in patients with positional obstructive sleep apnea syndrome. Sci Rep (2015) 0.76
Tracheobronchial foreign bodies: presentation and management in children and adults. Chest (1999) 5.93
Deterministic edge-preserving regularization in computed imaging. IEEE Trans Image Process (1997) 3.26
Microsatellite marker polymorphism and mapping in pea (Pisum sativum L.). Theor Appl Genet (2005) 1.79
Conservative versus operative treatment for Kienböck's disease. A retrospective study. J Hand Surg Br (1998) 1.68
Gemella haemolysans endocarditis. Clin Infect Dis (1993) 1.57
Microsleep during a simplified maintenance of wakefulness test. A validation study of the OSLER test. Am J Respir Crit Care Med (2001) 1.57
Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J Clin Microbiol (2001) 1.50
Management of simple snoring in adults. Monaldi Arch Chest Dis (1993) 1.42
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin. Thorax (1992) 1.40
Iatrogenic tracheobronchial lacerations. Ann Thorac Surg (1997) 1.38
Reassessment of lung volume measurement by helium dilution and by body plethysmography in chronic air-flow obstruction. Am Rev Respir Dis (1982) 1.37
Pharyngeal shape and dimensions in healthy subjects, snorers, and patients with obstructive sleep apnoea. Thorax (1990) 1.32
Identification of Vibrio cholerae by pyrolysis gas-liquid chromatography. Appl Microbiol (1973) 1.30
Comparative evaluation of five chromogenic media for detection, enumeration and identification of urinary tract pathogens. Eur J Clin Microbiol Infect Dis (1999) 1.30
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1984) 1.22
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med (2000) 1.19
High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnoea. Eur Respir J (2003) 1.19
Primary care spirometry. Eur Respir J (2008) 1.18
Propionibacterium acnes contamination in lumbar disc surgery. J Hosp Infect (2007) 1.17
Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood (2001) 1.16
Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. Chest (1995) 1.16
Genetic diversity within Pisum sativum using protein- and PCR-based markers. Theor Appl Genet (2004) 1.15
Demonstration of failure of body plethysmography in airway obstruction. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.15
Respiratory failure due to tracheobronchomalacia. Thorax (1996) 1.14
Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection. J Antimicrob Chemother (1990) 1.13
Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev (1997) 1.09
Ambulatory evaluation of sleep disturbance and therapeutic effects in sleep apnea syndrome by wrist activity monitoring. Am Rev Respir Dis (1987) 1.09
Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med (2001) 1.08
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood (2001) 1.08
Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.07
Emotional laryngeal wheezing: a new syndrome. Am Rev Respir Dis (1983) 1.06
Soft palate and oronasal breathing in humans. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.04
Characterization and nucleotide sequence of CARB-6, a new carbenicillin-hydrolyzing beta-lactamase from Vibrio cholerae. Antimicrob Agents Chemother (1999) 1.03
Normal pregnancy in primary alveolar hypoventilation treated with nocturnal nasal intermittent positive pressure ventilation. Eur Respir J (1995) 1.03
Solitary fibrous tumor of the pleura: a report of five cases diagnosed by transthoracic cutting needle biopsy. Chest (1997) 1.01
Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol (2008) 0.99
Evaluation of BacT/Alert 3D liquid culture system for recovery of mycobacteria from clinical specimens using sodium dodecyl (lauryl) sulfate-NaOH decontamination. J Clin Microbiol (2001) 0.99
Failure of tonsil and nose surgery in adults with long-standing severe sleep apnea syndrome. Arch Intern Med (1989) 0.99
Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. J Nucl Med (1982) 0.98
Expiratory flow limitation in awake sleep-disordered breathing subjects. Eur Respir J (1999) 0.98
Efficiency of blood culture bottles for the fungal sterility testing of corneal organ culture media. Br J Ophthalmol (2005) 0.96
Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial. Eur Respir J (2002) 0.96
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer (2003) 0.94
Outbreak of postoperative shoulder arthritis due to Propionibacterium acnes infection in nondebilitated patients. Infect Control Hosp Epidemiol (2006) 0.93
Expiratory flow limitation during sleep in heavy snorers and obstructive sleep apnoea patients. Eur Respir J (1996) 0.93
Human antibody response to the 70-Kd common neisserial antigen in patients and carriers of meningococci or non-pathogenic Neisseria. Ann Inst Pasteur Microbiol (1988) 0.93
Postoperative skin-flap decongestion, leeches and Aeromonas hydrophila. J Hosp Infect (1988) 0.92
[Surgical management of pelvic organ prolapse in women: laparoscopic or vaginal sacrocolpopexy?]. Gynecol Obstet Fertil (2008) 0.92
Spontaneous favorable outcome of tracheal laceration. Chest (1991) 0.92
Effects of nasal positive-pressure hyperventilation on the glottis in normal sleeping subjects. J Appl Physiol (1985) (1995) 0.92
Rupture of aortic aneurysm with right-sided haemothorax. Eur Respir J (1999) 0.92
Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin Microbiol Infect (2004) 0.91
Frequency dependence of plethysmographic volume in healthy and asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.91
Sensitivity and rapidity of blood culture bottles in the detection of cornea organ culture media contamination by bacteria and fungi. Br J Ophthalmol (2002) 0.91
Pattern of snoring in obstructive sleep apnea patients and in heavy snorers. Sleep (1991) 0.90
Studies on phagocytosis. I. Antigen clearance studies in rabbits. Immunology (1968) 0.90
Weight loss as a treatment for obstructive sleep apnoea. Sleep Med Rev (2000) 0.90
A role for an endosperm-localized subtilase in the control of seed size in legumes. New Phytol (2012) 0.90
"Sensitive tests" are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Rev Respir Dis (1987) 0.89
Genetic analysis of agronomic and quality traits in mustard (Brassica juncea). Theor Appl Genet (2004) 0.89
Upper airway anesthesia induces airflow limitation in awake humans. Am Rev Respir Dis (1992) 0.89
Development of an AFLP-based linkage map and localization of QTLs for seed fatty acid content in condiment mustard (Brassica juncea). Genome (2002) 0.88
EUS-FNA and FDG-PET are complementary procedures in the diagnosis of enlarged mediastinal lymph nodes. Acta Gastroenterol Belg (2008) 0.88
The soft palate and breathing. Am Rev Respir Dis (1986) 0.88
Joint reconstruction following trauma: comparison of microsurgical transfer and conventional methods: a report of 61 cases. J Hand Surg Br (1986) 0.87
Conservative treatment versus scaphotrapeziotrapezoid arthrodesis for Kienbock's disease. A retrospective study. Chir Main (2006) 0.87
Pattern of inhalation of tobacco smoke in pipe, cigarette, and never smokers. Am Rev Respir Dis (1985) 0.86
Infants are not obligatory nasal breathers. Am Rev Respir Dis (1985) 0.86
Reevaluation of the radiographic method for measurement of total lung capacity. Bull Eur Physiopathol Respir (1986) 0.86
Nasal obstruction and its impact on sleep-related breathing disorders. Rhinology (2005) 0.85
Use of a pair of blood culture bottles for sterility testing of corneal organ culture media. Br J Ophthalmol (2001) 0.85
Effects of nasal positive-pressure hyperventilation on the glottis in normal awake subjects. J Appl Physiol (1985) (1995) 0.84
Ventilatory and diaphragmatic EMG responses to negative-pressure ventilation in airflow obstruction. J Appl Physiol (1985) (1988) 0.84
Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur Respir J (2006) 0.84
Studies on phagocytosis. 3. Antigen clearance studies in invertebrates and poikilothermic vertebrates. Immunology (1968) 0.84
Adaptation to intermittent positive pressure ventilation applied through the nose during day and night. Eur Respir J (1989) 0.83
[Treatment of dorsal substance losses at the level of the proximal interphalangeal joint of the fingers]. Ann Chir Plast Esthet (1986) 0.83
Variational approach for edge-preserving regularization using coupled PDE's. IEEE Trans Image Process (1998) 0.83
HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy (2002) 0.83